Back

Real-world insights on anticoagulation therapies in non-valvular atrial fibrillation: a comprehensive electronic health record-based study using natural language processing and machine learning

7 April 2024 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session on atrial fibrillation and supraventricular tachycardia Oral Anticoagulation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Susana Fernandez

Pfizer Spain, Madrid (Spain)

116 More presentations in this session

Presentation thumbnail
Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group
Doctor L. Herzer (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation after transcatheter tricuspid valve repair: rhythm control strategies and outcomes
Doctor J. Schipper (Cologne, DE)
Abstract
Presentation thumbnail
Left atrial strain defines functional and structural remodeling in patients with persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Cryoballoon ablation for atrial fibrillation in young adults: a propensity-score matching comparison with an older cohort
Presentation thumbnail
Procedural safety and outcome of additional left atrial posterior wall ablation using pulse field ablation for atrial fibrillation
Doctor J. Tay Cheong Kiat (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session on atrial fibrillation and supraventricular tachycardia

The Event

Event poster

EHRA 2024

7 April 2024 08:00 CET
You may be interested in
thumbnail
Congress Presentation
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
thumbnail
Congress Presentation
Patient characteristics and real-world outcomes among atrial fibrillation patients treated with direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in Spain
thumbnail
Congress Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources